Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients.

× No keyword cloud information.

24 in total

Review 1. Newer uses of intravenous immunoglobulins as anti-infective agents.

Authors: J E Pennington
Journal: Antimicrob Agents Chemother Date: 1990-08 Impact factor: 5.191

2. Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients.

Authors: Bryan T Alexander; Lindsay M Hladnik; Kristan M Augustin; Ed Casabar; Peggy S McKinnon; Richard M Reichley; David J Ritchie; Peter Westervelt; Erik R Dubberke
Journal: Pharmacotherapy Date: 2010-06 Impact factor: 4.705

Review 3. How we treat cytomegalovirus in hematopoietic cell transplant recipients.

Authors: Michael Boeckh; Per Ljungman
Journal: Blood Date: 2009-03-18 Impact factor: 22.113

Review 4. Bone marrow transplantation. Part I--Allogeneic.

Authors: N J Chao; K G Blume
Journal: West J Med Date: 1989-12

5. Cytomegalovirus in hematopoietic stem cell transplant recipients.

Authors: Per Ljungman; Morgan Hakki; Michael Boeckh
Journal: Hematol Oncol Clin North Am Date: 2011-02 Impact factor: 3.722

Review 6. Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation.

Authors: M F Siadak; K Kopecky; K M Sullivan
Journal: Clin Exp Immunol Date: 1994-07 Impact factor: 4.330

7. Pulmonary complications after hematopoietic stem cell transplantation.

Authors: Do Hyoung Lim; Jeeyun Lee; Hong Ghi Lee; Byeong-Bae Park; Kyong Ran Peck; Won Sup Oh; Sang Hoon Ji; Se-Hoon Lee; Joon Oh Park; Kihyun Kim; Won Seog Kim; Chul Won Jung; Young Suk Park; Young-Hyuck Im; Won Ki Kang; Keunchil Park
Journal: J Korean Med Sci Date: 2006-06 Impact factor: 2.153

Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients.